AZACITIDINE
NDC 83774-102, azacitidine for, injection, powder, lyophilized, for solution, from Pilnova Pharma Inc.
- Product NDC
- 83774-102
- Status
- Listed
- Labeler
- Pilnova Pharma Inc
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207518
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83774-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZACITIDINE100 mg/1
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83774-102-01 | 83774010201 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (83774-102-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0095c67b-42f3-47e6-92db-f77843727bca
Use it
Look up 83774-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83774-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83774-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.